Author:
Roumie Christianne L.,Arbogast Patrick G.,Mitchel Edward F.,Griffin Marie R.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Cardiovascular Safety Review Rofecoxib. Available at: http://www.fda.gov/ohrms/dockets/ac/01/briefing/3677b2_06_cardio.pdf. Accessed July 26, 2004.
2. Merck. Press Release: Merck Announces Voluntary WorldWide Withdrawal of Vioxx. Merck and Co. Available at: http://www.merck.com/. Accessed September 30, 2004.
3. Solomon DH, Schneeweiss S, Glynn RJ, et al. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation. 2004;109:2068–73.
4. Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR. COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet. 2002;360:1071–3.
5. Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease. Pharmacoepidemiol Drug Safety. 2003;12:67–70.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献